First Pacific Advisors’s Edwards Lifesciences EW Stock Holding History

First Pacific Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,818	Closed	-$214K	–	195
2022 Q1	$214K	Hold	1,818	–	–	﹤0.01%	164
2021 Q4	$236K	Hold	1,818	–	–	﹤0.01%	158
2021 Q3	$206K	Hold	1,818	–	–	﹤0.01%	159
2021 Q2	$188K	Hold	1,818	–	–	﹤0.01%	162
2021 Q1	$152K	Hold	1,818	–	–	﹤0.01%	107
2020 Q4	$166K	Sell	1,818 -57	-3%	-$4.73K	﹤0.01%	146
2020 Q3	$150K	Hold	1,875	–	–	﹤0.01%	129
2020 Q2	$130K	Hold	1,875	–	–	﹤0.01%	136
2020 Q1	$118K	Buy	+1,875	New	+$135K	﹤0.01%	124

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Pacific Advisors's EW Position: Q2 2022 in Review

First Pacific Advisors sold out of Edwards Lifesciences (EW) in Q2 2022, closing a stake of 1,818 shares — an estimated $214K sold.

First Pacific Advisors first reported a position in EW in Q1 2020 and held it in 9 quarters. The position peaked at $236K in Q4 2021. 1,272 funds tracked by Wall St. Rank hold EW as of Q2 2022.

First Pacific Advisors reported no remaining Edwards Lifesciences position as of Q2 2022 after selling out during the quarter.
First Pacific Advisors sold 1,818 Edwards Lifesciences shares in Q2 2022, an estimated $214K.
First Pacific Advisors first reported a position in Edwards Lifesciences in Q1 2020 and held it in 9 quarters.
First Pacific Advisors's Edwards Lifesciences position peaked at $236K in Q4 2021.
1,272 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2022.

Based on First Pacific Advisors's 13F filing for Q2 2022, filed 8 Aug 2022.